Oruka Therapeutics, Inc. · NASDAQ:ORKA
Deep Track Capital, LP's stake in Oruka Therapeutics, Inc. fell to 4.47% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Deep Track Capital, LP's stake in Oruka Therapeutics, Inc. fell to 4.47%, 2,161,510 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 4.47%
- Shares
- 2,161,510
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 4.47% | 2,161,510 |
| Deep Track Biotechnology Master Fund, Ltd. | 3.92% | 1,899,455 |
| David Kroin | 4.47% | 2,161,510 |
| Deep Track Special Opportunities Fund, LP. | 0.54% | 262,055 |
Source
Related
- Oruka Therapeutics, Inc.
- Deep Track Capital, LP
- Oruka Therapeutics, Inc. shareholders
- Schedule 13G · Deep Track Capital, LP · May 13, 2025
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026